Cardiovascular Research Advance Access originally published online on September 10, 2008
Cardiovascular Research 2008 80(2):163-164; doi:10.1093/cvr/cvn245
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Activating SIRT1: a new strategy to prevent atherosclerosis?
Institut für Kardiovaskuläre Physiologie, Goethe-Universität, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany
* Corresponding author. Tel: +49 69 6301 6995; fax: +49 69 6301 7668. E-mail address: r.brandes{at}em.uni-frankfurt.de
The development of atherosclerosis is a complex, multi-step process, which is at least in part controlled by the functional state of the vascular endothelium. It is generally believed that the functional state of the endothelium is influenced by a broad set of cardiovascular risk factors and that endothelial dysfunction is the stereotypic cellular response to a broad range of different stimuli on the background of a poorly defined genetic predisposition.1
That such a concept represents an over-simplification has become evident through studies demonstrating maternal–foetal transmission of the atherosclerotic risk2 and ‘atherosclerotic programming’ of cells derived from mice with a pro-atherosclerotic phenotype.3 Such programming is the consequence of epigenetic modifications like DNA methylation or histone acetylation, processes that are controlled by several different enzyme families.
One of these enzymes, SIRT1, a class III histone deacetylase (HDAC), has gained considerable interest as a mediator of longevity induced by caloric restriction.4 Also in the vascular system, SIRT1 has been linked to aging: down-regulation of the protein-induced premature senescence and overexpression of SIRT1 protected endothelial cells against H2O2-induced senescence.5 SIRT1 belongs to the family of sirtuin proteins, which consists of seven family members (SIRT1–7). SIRT1, -2, -3, and -5 mediate NAD+-dependent deacetylation of 
-amino-acetylated lysine residues of proteins. This effect is not restricted to histones, and individual sirtuins have a broad spectrum of substrates and targets in the cell.6 Thus, functional changes mediated by SIRT1 are not necessarily the consequence of the histone deacetylase function of the protein.
SIRT1 is highly expressed in endothelial cells and controls their angiogenic function: it is involved in vascular growth of cultured endothelium, in the formation of the vascular network of the developing zebrafish, and even in ischaemia-induced neovascularization of the adult mouse.7 Such a profile suggests that SIRT1 maintains normal endothelial function and that overexpression of SIRT1 might be ‘vasoprotective’.
In this issue of Cardiovascular Research, evidence to strengthen this concept comes from the elegant study by Zhang et al.8 The authors characterized the SIRT1 expression in endothelial cells in response to pro-atherosclerotic stimuli and determined the impact of endothelial cell-specific overexpression of the enzyme on atherosclerosis development in ApoE knockout mice treated with a high-fat diet. In cultured human umbilical vein endothelial cells (HUVEC), they observed that oxidized LDL (oxLDL) as well as hydrogen peroxide (H2O2) down-regulate SIRT1. Overexpression of SIRT1 prevented the oxLDL-induced apoptosis of HUVECs, and this effect was mediated by a marked increase in the expression of endothelial NO synthase (eNOS). Accordingly, endothelial-specific overexpression of SIRT1 in ApoE–/– mice-induced eNOS and significantly blunted the high-fat diet-induced attenuation of endothelium-dependent relaxation in isolated aortic rings. Most importantly, endothelial-specific overexpression of SIRT1 also attenuated aortic plaque development in response to the high-fat diet in ApoE–/– mice.
It is well established that NO prevents endothelial cell apoptosis and senescence. Moreover, endogenous NO is anti-atherosclerotic, as genetic deletion of eNOS promotes atherosclerosis in ApoE–/– mice. Thus, it is conceivable that most of the effects observed in the present study are mediated by the SIRT1-dependent induction of eNOS. Indeed, by using inhibitors of SIRT1 and SIRT1 siRNA, Zhang et al. demonstrate a direct dependency of eNOS protein expression on SIRT1 activity. The underlying mechanisms of how SIRT1 controls eNOS expression are, however, still uncertain.
SIRT1 has been linked to longevity in response to caloric restriction. Interestingly, caloric restriction also increases eNOS expression.9 Whether this effect is involved in the overall extension of lifespan is questionable, as other important proteins such as p53 and Foxo transcription factors are also targets of this deacetylase.10,11
The activity of SIRT1 can be modulated directly by pharmacological compounds. The polyphenolic plant antioxidant resveratrol moderately increases the SIRT1 activity12 and has been shown to slow down the development of atherosclerosis in different mouse models13,14 (Figure 1). Recently, compounds that are 1000 times more potent than resveratrol have become available, and it has already been shown that these potential new drugs improve the glucose homeostasis.15 In the light of these beneficial effects, it could be speculated that these compounds might also be of value as a potential anti-atherosclerotic therapy.
|
 |
Notes |
|---|
The opinions expressed in this article are not necessarily those of the Editors of Cardiovascular Research or of the European Society of Cardiology.
|
References |
|---|
 Top References |
|---|
- Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation (2004) 109:III27–III32.[Medline]
- Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J (2002) 16:1348–1360.
[Abstract/Free Full Text] - Mayr M, Zampetaki A, Sidibe A, Mayr U, Yin X, De Souza AI, et al. Proteomic and metabolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice. Circ Res (2008) 102:1046–1056.
[Abstract/Free Full Text] - Guarente L, Picard F. Calorie restriction—the SIR2 connection. Cell (2005) 120:473–482.[CrossRef][Web of Science][Medline]
- Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol (2007) 43:571–579.[CrossRef][Web of Science][Medline]
- Haigis MC, Guarente LP. Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes Dev (2006) 20:2913–2921.
[Abstract/Free Full Text] - Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 21:2644–2658.
[Abstract/Free Full Text] - Zhang Q-J, Wang Z, Chen H-Z, Zhou S, Zheng W, Liu G, et al. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res (2008) 80:191–199.
[Abstract/Free Full Text] - Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA (2007) 104:14855–14860.
[Abstract/Free Full Text] - Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 107:137–148.[CrossRef][Web of Science][Medline]
- Vaziri H, Dessain SK, Ng EE, Imai SI, Frye RA, Pandita TK, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 107:149–159.[CrossRef][Web of Science][Medline]
- Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha. Cell (2006) 127:1109–1122.[CrossRef][Web of Science][Medline]
- Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes (2006) 55:2180–2191.
[Abstract/Free Full Text] - Fukao H, Ijiri Y, Miura M, Hashimoto M, Yamashita T, Fukunaga C, et al. Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Blood Coagul Fibrinol (2004) 15:441–446.[CrossRef][Web of Science][Medline]
- Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature (2007) 450:712–716.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
Related Article
- Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
- Qing-jun Zhang, Zhao Wang, Hou-zao Chen, Shuang Zhou, Wei Zheng, Guang Liu, Yu-sheng Wei, Hua Cai, De-pei Liu, and Chih-chuan Liang
Cardiovasc Res 2008 80: 191-199.[Abstract] [Full Text] [PDF]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||